These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1678778)

  • 21. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.
    Jonak ZL; Clark RK; Matour D; Trulli S; Craig R; Henri E; Lee EV; Greig R; Debouck C
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):23-32. PubMed ID: 8094000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.
    Cooney EL; McElrath MJ; Corey L; Hu SL; Collier AC; Arditti D; Hoffman M; Coombs RW; Smith GE; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1882-6. PubMed ID: 8446603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion.
    Dash B; McIntosh A; Barrett W; Daniels R
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1389-97. PubMed ID: 8207403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein.
    Benjouad A; Mabrouk K; Gluckman JC; Fenouillet E
    FEBS Lett; 1994 Mar; 341(2-3):244-50. PubMed ID: 8137947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs.
    Taylor DL; Sunkara PS; Liu PS; Kang MS; Bowlin TL; Tyms AS
    AIDS; 1991 Jun; 5(6):693-8. PubMed ID: 1652979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
    Papandreou MJ; Idziorek T; Miquelis R; Fenouillet E
    FEBS Lett; 1996 Jan; 379(2):171-6. PubMed ID: 8635586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucosidase inhibitors for treatment of HIV-1 infection.
    Ratner L
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):165-73. PubMed ID: 1540404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement activation by gp160 glycoprotein of HIV-1.
    Thieblemont N; Haeffner-Cavaillon N; Weiss L; Maillet F; Kazatchkine MD
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):229-33. PubMed ID: 8471312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
    Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K
    Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of novel 1-deoxynojirimycin derivatives on HIV-1 replication.
    Shimizu H; Tsuchie H; Yoshida K; Morikawa S; Tsuruoka T; Yamamoto H; Ushijima H; Kitamura T
    AIDS; 1990 Oct; 4(10):975-9. PubMed ID: 2148090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
    Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
    Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
    Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural properties of HIV-1 Env fused with the 14-kDa vaccinia virus envelope protein.
    Rodriguez JR; Rodriguez D; Esteban M
    Virology; 1991 Apr; 181(2):742-8. PubMed ID: 2014647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin.
    Hart ML; Saifuddin M; Spear GT
    J Gen Virol; 2003 Feb; 84(Pt 2):353-360. PubMed ID: 12560567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
    Haidar M; Seddiki N; Gluckman JC; Gattegno L
    Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.